The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease

Post time 2024-4-28 06:31:14

journal：Journal of Gastroenterology and Hepatology

Authors：Susrichit Phrueksotsai; Kanokwan Pinyopornpanish; Juntima Euathrongchit; Apinya Leerapun; Arintaya Phrommintikul; Supawan Buranapin; Nipon Chattipakorn; Satawat Thongsawat

Published date：2021-10-

DOI：10.1111/jgh.15580

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgh.15580

Article link：http://dx.doi.org/10.1111/jgh.15580

Article Source：Wiley。

Remark：URGENT HELP

Post time 2024-4-28 06:31:15

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease